{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:46:56Z","timestamp":1792633616845,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1756-0500-6-542","type":"journal-article","created":{"date-parts":[[2013,12,19]],"date-time":"2013-12-19T00:29:12Z","timestamp":1387412952000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Evaluating real-time immunohistochemistry on multiple tissue samples, multiple targets and multiple antibody labeling methods"],"prefix":"10.1186","volume":"6","author":[{"given":"Louise","family":"Dubois","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Asplund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Bj\u00f6rkelund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,18]]},"reference":[{"issue":"4","key":"2552_CR1","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1354\/vp.42-4-405","volume":"42","author":"JA Ramos-Vara","year":"2005","unstructured":"Ramos-Vara JA: Technical aspects of immunohistochemistry. Veter Pathol. 2005, 42 (4): 405-426. 10.1354\/vp.42-4-405.","journal-title":"Veter Pathol"},{"issue":"1","key":"2552_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1136\/jclinpath-2012-201140","volume":"66","author":"CM McCourt","year":"2013","unstructured":"McCourt CM, Boyle D, James J, Salto-Tellez M: Immunohistochemistry in the era of personalised medicine. J Clin Pathol. 2013, 66 (1): 58-61. 10.1136\/jclinpath-2012-201140.","journal-title":"J Clin Pathol"},{"issue":"7","key":"2552_CR3","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/j.1464-410X.2005.05452.x","volume":"95","author":"T Gardmark","year":"2005","unstructured":"Gardmark T, Wester K, De la Torre M, Carlsson J, Malmstrom PU: Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases. BJU Int. 2005, 95 (7): 982-986. 10.1111\/j.1464-410X.2005.05452.x.","journal-title":"BJU Int"},{"issue":"14","key":"2552_CR4","first-page":"5346","volume":"9","author":"TT Junttila","year":"2003","unstructured":"Junttila TT, Laato M, Vahlberg T, Soderstrom KO, Visakorpi T, Isola J, Elenius K: Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients. Clin Cancer Res. 2003, 9 (14): 5346-5357.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2552_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/hyb.1998.17.313","volume":"17","author":"RC Bast Jr","year":"1998","unstructured":"Bast RC, Pusztai L, Kerns BJ, MacDonald JA, Jordan P, Daly L, Boyer CM, Mendelsohn J, Berchuck A: Co expression of the HER-2 gene product, p185HER-2, and epidermal growth factor receptor, p170EGF-R, on epithelial ovarian cancers and normal tissues. Hybridoma. 1998, 17 (4): 313-321. 10.1089\/hyb.1998.17.313.","journal-title":"Hybridoma"},{"issue":"3","key":"2552_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ctrv.2006.01.001","volume":"32","author":"A Serrano-Olvera","year":"2006","unstructured":"Serrano-Olvera A, Duenas-Gonzalez A, Gallardo-Rincon D, Candelaria M, De la Garza-Salazar J: Prognostic, predictive and therapeutic implications of HER2 in invasive epithelial ovarian cancer. Cancer Treatment Rev. 2006, 32 (3): 180-190. 10.1016\/j.ctrv.2006.01.001.","journal-title":"Cancer Treatment Rev"},{"issue":"8","key":"2552_CR7","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1177\/002215540104900801","volume":"49","author":"SR Shi","year":"2001","unstructured":"Shi SR, Cote RJ, Taylor CR: Antigen retrieval techniques: current perspectives. J Histochem Cytochem. 2001, 49 (8): 931-937. 10.1177\/002215540104900801.","journal-title":"J Histochem Cytochem"},{"issue":"8","key":"2552_CR8","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/jnci\/95.8.628","volume":"95","author":"A Vincent-Salomon","year":"2003","unstructured":"Vincent-Salomon A, MacGrogan G, Couturier J, Arnould L, Mathoulin-Pelissier S, Groupe d\u2019Etude des Facteurs Pronostiques par Immunohistochime dans les Cancers du S: Re: HER2 testing in the real world. J Natl Cancer Inst. 2003, 95 (8): 628-author reply 628-629","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"2552_CR9","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.apradiso.2010.06.003","volume":"68","author":"L Gedda","year":"2010","unstructured":"Gedda L, Bjorkelund H, Andersson K: Real-time immunohistochemistry analysis of embedded tissue. Appl Radiat Isotopes. 2010, 68 (12): 2372-2376. 10.1016\/j.apradiso.2010.06.003.","journal-title":"Appl Radiat Isotopes"},{"key":"2552_CR10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.6000\/1927-7229.2013.02.02.3","volume":"2","author":"K Andersson","year":"2013","unstructured":"Andersson K: Bringing time into molecular and cellular biology. J Anal Oncol. 2013, 2: 65-68.","journal-title":"J Anal Oncol"},{"key":"2552_CR11","volume-title":"Appl Immunohistochem Mol Morphol","author":"L Gedda","year":"2013","unstructured":"Gedda L, Bjorkelund H, Lebel L, Asplund A, Dubois L, Wester K, Penagos N, Malmqvist M, Andersson K: Evaluation of real-time immunohistochemistry and Interaction Map as an alternative objective assessment of HER2 expression in human breast cancer tissue. Appl Immunohistochem Mol Morphol. 2013, Epub ahead of print"},{"issue":"8","key":"2552_CR12","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.apradiso.2006.03.002","volume":"64","author":"H Bjorke","year":"2006","unstructured":"Bjorke H, Andersson K: Automated, high-resolution cellular retention and uptake studies in vitro. Appl Radiat Isot. 2006, 64 (8): 901-905. 10.1016\/j.apradiso.2006.03.002.","journal-title":"Appl Radiat Isot"},{"issue":"3","key":"2552_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/jmr.883","volume":"21","author":"M Nestor","year":"2008","unstructured":"Nestor M, Andersson K, Lundqvist H: Characterization of 111In and 177Lu-labeled antibodies binding to CD44v6 using a novel automated radioimmunoassay. J Mol Recognit. 2008, 21 (3): 179-183. 10.1002\/jmr.883.","journal-title":"J Mol Recognit"},{"issue":"5","key":"2552_CR14","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s11307-010-0407-9","volume":"13","author":"G Malviya","year":"2011","unstructured":"Malviya G, de Vries EF, Dierckx RA, Signore A: Synthesis and evaluation of 99mTc-labelled monoclonal antibody 1D09C3 for molecular imaging of major histocompatibility complex class II protein expression. Mol Imag Biol. 2011, 13 (5): 930-939. 10.1007\/s11307-010-0407-9.","journal-title":"Mol Imag Biol"},{"issue":"5","key":"2552_CR15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/bab.1033","volume":"59","author":"J Nilvebrant","year":"2012","unstructured":"Nilvebrant J, Kuku G, Bj\u00f6rkelund H, Nestor M: Selection and in vitro characterization of human CD44v6-binding antibody fragments. Biotechnol Appl Biochem. 2012, 59 (5): 367-380. 10.1002\/bab.1033.","journal-title":"Biotechnol Appl Biochem"},{"issue":"11","key":"2552_CR16","doi-asserted-by":"publisher","first-page":"e49579","DOI":"10.1371\/journal.pone.0049579","volume":"7","author":"L Ekerljung","year":"2012","unstructured":"Ekerljung L, Lennartsson J, Gedda L: The HER2-binding affibody molecule (Z(HER2ratio342))(2) increases radio sensitivity in SKBR-3 cells. PloS one. 2012, 7 (11): e49579-10.1371\/journal.pone.0049579.","journal-title":"PloS one"},{"issue":"1","key":"2552_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bbrc.2012.10.008","volume":"428","author":"D Altschuh","year":"2012","unstructured":"Altschuh D, Bjorkelund H, Strandgard J, Choulier L, Malmqvist M, Andersson K: Deciphering complex protein interaction kinetics using Interaction Map. Biochem Biophys Res Commun. 2012, 428 (1): 74-79. 10.1016\/j.bbrc.2012.10.008.","journal-title":"Biochem Biophys Res Commun"},{"key":"2552_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/1479-5876-9-114","volume":"9","author":"L Jonsson","year":"2011","unstructured":"Jonsson L, Bergman J, Nodin B, Manjer J, Ponten F, Uhlen M, Jirstrom K: Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmo Diet and Cancer Study. J Translat Med. 2011, 9: 114-10.1186\/1479-5876-9-114.","journal-title":"J Translat Med"},{"issue":"2","key":"2552_CR19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1006\/geno.2000.6291","volume":"68","author":"RD Machado","year":"2000","unstructured":"Machado RD, Pauciulo MW, Fretwell N, Veal C, Thomson JR, Vilarino Guell C, Aldred M, Brannon CA, Trembath RC, Nichols WC: A physical and transcript map based upon refinement of the critical interval for PPH1, a gene for familial primary pulmonary hypertension. The International PPH Consortium. Genomics. 2000, 68 (2): 220-228. 10.1006\/geno.2000.6291.","journal-title":"Genomics"},{"issue":"7","key":"2552_CR20","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/humu.20515","volume":"28","author":"P Leoyklang","year":"2007","unstructured":"Leoyklang P, Suphapeetiporn K, Siriwan P, Desudchit T, Chaowanapanja P, Gahl WA, Shotelersuk V: Heterozygous nonsense mutation SATB2 associated with cleft palate, osteoporosis, and cognitive defects. Human Mutat. 2007, 28 (7): 732-738. 10.1002\/humu.20515.","journal-title":"Human Mutat"},{"issue":"2","key":"2552_CR21","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/ijc.2910430218","volume":"43","author":"R Seshadri","year":"1989","unstructured":"Seshadri R, Matthews C, Dobrovic A, Horsfall DJ: The significance of oncogene amplification in primary breast cancer. Int J Cancer. 1989, 43 (2): 270-272. 10.1002\/ijc.2910430218.","journal-title":"Int J Cancer"},{"issue":"13","key":"2552_CR22","first-page":"2825","volume":"58","author":"J Baselga","year":"1998","unstructured":"Baselga J, Norton L, Albanell J, Kim YM, Mendelsohn J: Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2\/neu overexpressing human breast cancer xenografts. Cancer Res. 1998, 58 (13): 2825-2831.","journal-title":"Cancer Res"},{"issue":"9","key":"2552_CR23","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1097\/MNM.0b013e3283483e1c","volume":"32","author":"P Barta","year":"2011","unstructured":"Barta P, Bjorkelund H, Andersson K: Circumventing the requirement of binding saturation for receptor quantification using interaction kinetic extrapolation. Nucl Med Comm. 2011, 32 (9): 863-867. 10.1097\/MNM.0b013e3283483e1c.","journal-title":"Nucl Med Comm"},{"issue":"6","key":"2552_CR24","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/j.1476-5381.2009.00604.x","volume":"161","author":"EC Hulme","year":"2010","unstructured":"Hulme EC, Trevethick MA: Ligand binding assays at equilibrium: validation and interpretation. Br J Pharmacol. 2010, 161 (6): 1219-1237. 10.1111\/j.1476-5381.2009.00604.x.","journal-title":"Br J Pharmacol"},{"issue":"1\u20132","key":"2552_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-1759(03)00206-0","volume":"278","author":"M Wadhwa","year":"2003","unstructured":"Wadhwa M, Bird C, Dilger P, Gaines-Das R, Thorpe R: Strategies for detection, measurement and characterization of unwanted antibodies induced by therapeutic biologicals. J Immun Methods. 2003, 278 (1\u20132): 1-17.","journal-title":"J Immun Methods"},{"key":"2552_CR26","volume-title":"Evaluation of tissue processing factors affecting HER2 IHC staining intensity in breast cancer cell lines","author":"K Jensen","year":"2012","unstructured":"Jensen K, Erickson J, Webster S, Pedersen H: Evaluation of tissue processing factors affecting HER2 IHC staining intensity in breast cancer cell lines. Cancer Res. 2012, 12 (24): Supplement 3"},{"key":"2552_CR27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/194495a0","volume":"194","author":"WM Hunter","year":"1962","unstructured":"Hunter WM, Greenwood FC: Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962, 194: 495-496. 10.1038\/194495a0.","journal-title":"Nature"},{"issue":"3","key":"2552_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1369\/jhc.2009.954321","volume":"58","author":"L Paavilainen","year":"2010","unstructured":"Paavilainen L, Edvinsson A, Asplund A, Hober S, Kampf C, Ponten F, Wester K: The impact of tissue fixatives on morphology and antibody-based protein profiling in tissues and cells. J Histochem Cytochem. 2010, 58 (3): 237-246. 10.1369\/jhc.2009.954321.","journal-title":"J Histochem Cytochem"},{"key":"2552_CR29","first-page":"28","volume":"1","author":"I Buchwalow","year":"2011","unstructured":"Buchwalow I, Samoilova V, Boecker W, Tiemann M: Non-specific binding of antibodies in immunohistochemistry: fallacies and facts. Sci Reports. 2011, 1: 28-","journal-title":"Sci Reports"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-6-542.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T05:29:28Z","timestamp":1688880568000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-6-542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2552"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-6-542","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"13 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"542"}}